www.fdanews.com/articles/183370-adherium-receives-fda-510k-clearance-for-next-generation-smartinhaler
Adherium Receives FDA 510(k) Clearance for Next Generation Smartinhaler
September 6, 2017
The FDA cleared Adherium’s SmartTouch inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler.
The device is installed onto a patient’s inhaler to monitor and encourage medication adherence as part of a self-management plan.
The device records the date and time the inhaler is used and automatically transmits the information to an app on the patient’s phone or tablet.